Table 3

Clinical and electrophysiological data of patients with syncope according to the patient's age

6–19 years20–85 years
Number2150
Age (years)15 ± 343 ± 14
Male sex, %14 (67)23 (46)NS
AVRT induction, %9 (43)28 (56)NS
AF induction, %6 (28.5)16 (32)NS
Antidromic T, %3 (14)3 (6)NS
Max rate CS (bpm)194 ± 59196 ± 58NS
Max rate iso (bpm)235 ± 79245 ± 71NS
Malignant form, %7 (33)11 (22)NS
6–19 years20–85 years
Number2150
Age (years)15 ± 343 ± 14
Male sex, %14 (67)23 (46)NS
AVRT induction, %9 (43)28 (56)NS
AF induction, %6 (28.5)16 (32)NS
Antidromic T, %3 (14)3 (6)NS
Max rate CS (bpm)194 ± 59196 ± 58NS
Max rate iso (bpm)235 ± 79245 ± 71NS
Malignant form, %7 (33)11 (22)NS
Table 3

Clinical and electrophysiological data of patients with syncope according to the patient's age

6–19 years20–85 years
Number2150
Age (years)15 ± 343 ± 14
Male sex, %14 (67)23 (46)NS
AVRT induction, %9 (43)28 (56)NS
AF induction, %6 (28.5)16 (32)NS
Antidromic T, %3 (14)3 (6)NS
Max rate CS (bpm)194 ± 59196 ± 58NS
Max rate iso (bpm)235 ± 79245 ± 71NS
Malignant form, %7 (33)11 (22)NS
6–19 years20–85 years
Number2150
Age (years)15 ± 343 ± 14
Male sex, %14 (67)23 (46)NS
AVRT induction, %9 (43)28 (56)NS
AF induction, %6 (28.5)16 (32)NS
Antidromic T, %3 (14)3 (6)NS
Max rate CS (bpm)194 ± 59196 ± 58NS
Max rate iso (bpm)235 ± 79245 ± 71NS
Malignant form, %7 (33)11 (22)NS
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close